Dr. Eric Liu, internationally recognized surgeon, specializing in neuroendocrine tumors (NET), will be joining Rocky Mountain Cancer Centers (RMCC) on June 1st. He is among a select group of specialists in the United States dedicated to the treatment of this complex and often misdiagnosed cancer, best known as the “cancer that Steve Jobs had.” Dr. Liu completed a fellowship under Dr. Kjell Oberg in Sweden, considered the pioneer of neuroendocrine research, and was responsible for establishing the first clinical trial in the United States for the Gallium 68 PET/CT, an important tool in diagnosing patients with NET.
Dr. Liu was previously at Vanderbilt University in Nashville, TN, where he established a Neuroendocrine Center. He and medical oncologist Dr. Allen Cohn will be heading up a new Neuroendocrine Tumor Center here in Denver based out of Rocky Mountain Cancer Centers’ Midtown location and in conjunction with HealthONE’s Presbyterian/St. Luke’s Medical Center.